The number of hypertension patients in China is estimated to surpass 300 million with one in three adults suffering from it.
Out of all the dyazides, angiotension receptor blocker (ARB) is among a new generation which grows fast. Ever since the appearance of losartan which has been first applied in the clinic, 8 kinds of similar drugs have come out...
More...





